2026– date –
-
Nano-Infused Resins Dramatically Boost Prepreg Conductivity for Aerospace Composites
PatSnap Eureka Singapore Overview Nanotechnology is revolutionizing prepreg composites by integrating conductive nanofillers into resin systems, achieving conductivity gains up to 10^6 S/m while preserving mechanical integrity. Carbon na... -
Overcoming Translational Hurdles: Nanotechnology Paves Way for Advanced Cancer Immunotherapies
MDPI Switzerland Overview Nanotechnology offers significant potential in developing highly effective cancer vaccines by enhancing tumor-specific immune responses. Diverse nanoparticle platforms, including liposomes, polymers, inorganic n... -
Advanced Nanopatterning: Nanoimprint Lithography and Directed Self-Assembly Drive Next-Gen Semiconductor Metrology
Semiconductor Engineering USA Overview As semiconductor manufacturing confronts Moore's Law limitations, Nanoimprint Lithography (NIL) and Directed Self-Assembly (DSA) are emerging as critical advanced patterning technologies. These tech... -
Nanoimprint Lithography Poised to Revolutionize Nanoscale Device Fabrication Below 10nm
AZoNano Australia Overview Nanoimprint Lithography (NIL) offers a groundbreaking alternative to traditional photolithography, enabling direct mechanical patterning at the nanoscale without relying on light or electron beam exposure. This... -
Avaí Bio Establishes GMP-Grade Master Cell Bank for Alpha-Klotho Anti-Aging Program, Advancing Cell Therapy Toward Commercialization
PR Newswire (via USA News Group) USA Overview Avaí Bio has achieved a critical manufacturing milestone by completing its GMP-grade Master Cell Bank (MCB) for the alpha-Klotho anti-aging program. This MCB ensures a high-quality, standardi... -
Japan: AMCHEPRY® for Parkinson’s (~$350,600) and RiHEART® for Severe Heart Failure (~$63,500+) iPSC Cell Therapies Show Positive Early Clinical Results in 7 Patients
Reddit (r/stemcells) Japan Overview Early clinical trials for Japan-originated iPSC cell therapies, AMCHEPRY® for Parkinson's disease and RiHEART® for severe ischemic heart failure, have shown positive results in a total of seven patient... -
Allogene Therapeutics’ Anti-B7-H3 Allogeneic CAR γδ T Cell Therapy QH104 Shows Favorable Safety, Disease Stabilization in Leptomeningeal Metastasis Phase 1 Trial
PubMed USA Overview Allogene Therapeutics' anti-B7-H3 allogeneic CAR γδ T cell therapy, QH104, demonstrated a favorable safety profile and promising efficacy in a Phase 1 clinical trial for patients with leptomeningeal metastasis (LM) fr... -
Europe’s Biotech Vanguard: Ori Biotech’s Modular Automation Reshapes Cell and Gene Therapy Manufacturing
PharmTech ヨーロッパ Overview European biotechnology firms are pioneering advanced manufacturing solutions to overcome critical production hurdles in cell and gene therapies. Ori Biotech, in strategic collaborations with Cell Therapies, ... -
Genprex’s Reqorsa® Gene Therapy Extends Progression-Free Survival in NSCLC Patients with High Trop-2/Low PTEN Biomarkers, ASCO 2026 Data Shows
Genprex, Inc. USA Overview Genprex, Inc. presented positive clinical data on predictive biomarkers for its Reqorsa® gene therapy in non-small cell lung cancer (NSCLC) patients at the 2026 ASCO Annual Meeting. The data indicates that pati... -
CELLINK’s 3D Bioprinting Expands Organoid Production, Accelerating Drug Discovery and Regenerative Medicine
ATCG India India Overview CELLINK's 3D bioprinting technology is driving the future of cell culture by providing innovative solutions to support research in cultivated meat, tissue engineering, and regenerative medicine. Integrating orga...
